Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 11;27(16):4599–4609. doi: 10.1158/1078-0432.CCR-21-0205

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©2021 The Authors; Published by the American Association for Cancer Research

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs International 4.0 License.

PMC Copyright notice

Figure 3. RNA expression–based immune score differs among UROMOL subclasses and is associated with RFS after BCG. A, Average expression counts for markers of various immune cell types for each patient. B–E, RFS by immune score in the entire MSK cohort (B); MSK patients treated with BCG (C); entire UROMOL cohort (D), UROMOL patients treated with BCG (E). — RNA expression–based immune score differs among UROMOL subclasses and is associated with RFS after BCG. A, Average expression counts for markers of various immune cell types for each patient. B–E, RFS by immune score in the entire MSK cohort (B); MSK patients treated with BCG (C); entire UROMOL cohort (D), UROMOL patients treated with BCG (E).